Literature DB >> 8995635

A novel terminal resolution-like site in the adeno-associated virus type 2 genome.

X S Wang1, A Srivastava.   

Abstract

The adeno-associated virus 2 (AAV) contains a single-stranded DNA genome of which the terminal 145 nucleotides are palindromic and form T-shaped hairpin structures. These inverted terminal repeats (ITRs) play an important role in AAV DNA replication and resolution, since each of the ITRs contains a terminal resolution site (trs) that is the target site for the AAV rep gene products (Rep). However, the Rep proteins also interact with the AAV DNA sequences that lie outside the ITRs, and the ITRs also play a crucial role in excision of the proviral genome from latently infected cells or from recombinant AAV plasmids. To distinguish between Rep-mediated excision of the viral genome during rescue from recombinant AAV plasmids and the Rep-mediated resolution of the ITRs during AAV DNA replication, we constructed recombinant AAV genomes that lacked either the left or the right ITR sequence and one of the Rep-binding sites (RBSs). No rescue and replication of the AAV genome occurred from these plasmids following transfection into adenovirus type 2-infected human KB cells, as expected. However, excision and abundant replication of the vector sequences was clearly detected from the plasmid that lacked the AAV left ITR, suggesting the existence of an additional putative excision site in the left end of the AAV genome. This site was precisely mapped to one of the AAV promoters at map unit 5 (AAV p5) that also contains an RBS. Furthermore, deletion of this RBS abolished the rescue and replication of the vector sequences. These studies suggest that the Rep-mediated cleavage at the RBS during viral DNA replication may, in part, account for the generation of the AAV defective interfering particles.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 8995635      PMCID: PMC191166     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  34 in total

1.  Asymmetric replication in vitro from a human sequence element is dependent on adeno-associated virus Rep protein.

Authors:  E Urcelay; P Ward; S M Wiener; B Safer; R M Kotin
Journal:  J Virol       Date:  1995-04       Impact factor: 5.103

2.  Identification of linear DNA sequences that specifically bind the adeno-associated virus Rep protein.

Authors:  D M McCarty; D J Pereira; I Zolotukhin; X Zhou; J H Ryan; N Muzyczka
Journal:  J Virol       Date:  1994-08       Impact factor: 5.103

3.  Interaction of the adeno-associated virus Rep protein with a sequence within the A palindrome of the viral terminal repeat.

Authors:  D M McCarty; J H Ryan; S Zolotukhin; X Zhou; N Muzyczka
Journal:  J Virol       Date:  1994-08       Impact factor: 5.103

4.  Features of the adeno-associated virus origin involved in substrate recognition by the viral Rep protein.

Authors:  R O Snyder; D S Im; T Ni; X Xiao; R J Samulski; N Muzyczka
Journal:  J Virol       Date:  1993-10       Impact factor: 5.103

5.  Mapping and direct visualization of a region-specific viral DNA integration site on chromosome 19q13-qter.

Authors:  R M Kotin; J C Menninger; D C Ward; K I Berns
Journal:  Genomics       Date:  1991-07       Impact factor: 5.736

6.  Adeno-associated virus DNA replication in vitro: activation by a maltose binding protein/Rep 68 fusion protein.

Authors:  P Ward; E Urcelay; R Kotin; B Safer; K I Berns
Journal:  J Virol       Date:  1994-09       Impact factor: 5.103

7.  Partial purification of adeno-associated virus Rep78, Rep52, and Rep40 and their biochemical characterization.

Authors:  D S Im; N Muzyczka
Journal:  J Virol       Date:  1992-02       Impact factor: 5.103

8.  In vitro replication of adeno-associated virus DNA.

Authors:  T H Ni; X Zhou; D M McCarty; I Zolotukhin; N Muzyczka
Journal:  J Virol       Date:  1994-02       Impact factor: 5.103

9.  Rescue of the adeno-associated virus 2 genome correlates with alterations in DNA-modifying enzymes in human cells.

Authors:  P Nahreini; A Srivastava
Journal:  Intervirology       Date:  1992       Impact factor: 1.763

10.  Targeted integration of adeno-associated virus (AAV) into human chromosome 19.

Authors:  R J Samulski; X Zhu; X Xiao; J D Brook; D E Housman; N Epstein; L A Hunter
Journal:  EMBO J       Date:  1991-12       Impact factor: 11.598

View more
  20 in total

1.  Characterization of wild-type adeno-associated virus type 2-like particles generated during recombinant viral vector production and strategies for their elimination.

Authors:  X S Wang; B Khuntirat; K Qing; S Ponnazhagan; D M Kube; S Zhou; V J Dwarki; A Srivastava
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

2.  Rescue and autonomous replication of adeno-associated virus type 2 genomes containing Rep-binding site mutations in the viral p5 promoter.

Authors:  X S Wang; A Srivastava
Journal:  J Virol       Date:  1998-06       Impact factor: 5.103

3.  Evidence for packaging of rep-cap sequences into adeno-associated virus (AAV) type 2 capsids in the absence of inverted terminal repeats: a model for generation of rep-positive AAV particles.

Authors:  Pascale Nony; Gilliane Chadeuf; Jacques Tessier; Philippe Moullier; Anna Salvetti
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

4.  Establishment of a novel cell line for the enhanced production of recombinant adeno-associated virus vectors for gene therapy.

Authors:  Stifani Satkunanathan; Jun Wheeler; Robin Thorpe; Yuan Zhao
Journal:  Hum Gene Ther       Date:  2014-09-11       Impact factor: 5.695

5.  Adeno-Associated Virus Vector Mobilization, Risk Versus Reality.

Authors:  Liujiang Song; R Jude Samulski; Matthew L Hirsch
Journal:  Hum Gene Ther       Date:  2020-10       Impact factor: 5.695

6.  Novel cis-acting replication element in the adeno-associated virus type 2 genome is involved in amplification of integrated rep-cap sequences.

Authors:  P Nony; J Tessier; G Chadeuf; P Ward; A Giraud; M Dugast; R M Linden; P Moullier; A Salvetti
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

7.  The cellular TATA binding protein is required for rep-dependent replication of a minimal adeno-associated virus type 2 p5 element.

Authors:  Achille François; Mickaël Guilbaud; Rafi Awedikian; Gilliane Chadeuf; Philippe Moullier; Anna Salvetti
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

8.  Evidence for the failure of adeno-associated virus serotype 5 to package a viral genome > or = 8.2 kb.

Authors:  Yi Lai; Yongping Yue; Dongsheng Duan
Journal:  Mol Ther       Date:  2009-11-10       Impact factor: 11.454

9.  Adeno-associated virus site-specific integration and AAVS1 disruption.

Authors:  Henry Hamilton; Janette Gomos; Kenneth I Berns; Erik Falck-Pedersen
Journal:  J Virol       Date:  2004-08       Impact factor: 5.103

10.  Rescue of the adeno-associated virus genome from a plasmid vector: evidence for rescue by replication.

Authors:  Peter Ward; Per Elias; R Michael Linden
Journal:  J Virol       Date:  2003-11       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.